Skip to content

Commit

Permalink
Update snapshots after formatters changes in wrapping (#65)
Browse files Browse the repository at this point in the history 
Co-authored-by: ayogasekaram <abinaya.yogasekaram@contractors.roche.com>
  • Loading branch information
@Melkiades @ayogasekaram
Melkiades and ayogasekaram authored Oct 13, 2023
1 parent 7bbef10 commit 00bbf7d
Show file tree
Hide file tree
Showing 14 changed files with 434 additions and 430 deletions.
8 changes: 4 additions & 4 deletions DESCRIPTION
View file
Original file line number Diff line number Diff line change
Expand Up @@ -21,11 +21,11 @@ License: Apache License 2.0 | file LICENSE
URL: https://github.com/insightsengineering/scda.test/
BugReports: https://github.com/insightsengineering/scda.test/issues
Depends:
formatters (>= 0.5.1.9005),
formatters (>= 0.5.3.9002),
R (>= 3.6),
rlistings (>= 0.2.3.9003),
rtables (>= 0.6.2.9003),
tern (>= 0.8.5.9013)
rlistings (>= 0.2.5.9002),
rtables (>= 0.6.4.9003),
tern (>= 0.9.1.9005)
Imports:
scda (>= 0.1.6.9012),
scda.2022 (>= 0.1.5.9002)
Expand Down
100 changes: 50 additions & 50 deletions tests/testthat/_snaps/listing_egl01.md
View file

Large diffs are not rendered by default.

94 changes: 47 additions & 47 deletions tests/testthat/_snaps/listing_lbl01.md
View file
Original file line number Diff line number Diff line change
Expand Up @@ -10,56 +10,56 @@
Study Last Dose of ALT CRP IGA
Center/Patient ID Treatment Day Study Drug (U/L / NCI CTCAE grade) (mg/L / NCI CTCAE grade) (g/L / NCI CTCAE grade)
————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
BRA-1/id-105 A: Drug X 80 NA 4.30 / L4 9.09 2.84
149 69 24.70 9.15 2.93
314 165 24.87 10.89 / H2 2.66
398 84 3.67 / L3 8.14 2.86
470 72 18.55 10.59 / H3 2.88
528 58 7.73 10.09 / H3 2.93
535 7 23.51 9.20 2.88
BRA-1/id-134 A: Drug X 225 NA 7.37 10.46 / H1 2.86
227 2 16.42 7.43 / L1 2.76
255 28 11.16 9.41 2.75
269 14 15.89 10.02 / H4 2.84
357 88 24.35 8.01 2.86
436 79 16.03 8.51 2.98
440 4 17.21 7.63 / L3 2.78
BRA-1/id-141 C: Combination 4 NA 11.32 9.21 2.84
52 48 25.77 10.00 / H2 2.69
189 137 32.73 9.08 2.85
262 73 34.69 8.81 2.81
386 124 8.58 8.81 2.81
425 39 19.58 8.79 2.87
BRA-1/id-105 A: Drug X 80 NA 4.30 / L4 9.09 2.84
149 69 24.70 9.15 2.93
314 165 24.87 10.89 / H2 2.66
398 84 3.67 / L3 8.14 2.86
470 72 18.55 10.59 / H3 2.88
528 58 7.73 10.09 / H3 2.93
535 7 23.51 9.20 2.88
BRA-1/id-134 A: Drug X 225 NA 7.37 10.46 / H1 2.86
227 2 16.42 7.43 / L1 2.76
255 28 11.16 9.41 2.75
269 14 15.89 10.02 / H4 2.84
357 88 24.35 8.01 2.86
436 79 16.03 8.51 2.98
440 4 17.21 7.63 / L3 2.78
BRA-1/id-141 C: Combination 4 NA 11.32 9.21 2.84
52 48 25.77 10.00 / H2 2.69
189 137 32.73 9.08 2.85
262 73 34.69 8.81 2.81
386 124 8.58 8.81 2.81
425 39 19.58 8.79 2.87
730 305 23.28 8.92 3.01 / H3
BRA-1/id-236 B: Placebo 12 NA 17.43 10.54 / H2 3.05 / H1
275 263 29.52 9.50 2.85
431 156 22.29 9.11 2.88
781 350 10.06 9.10 2.82
794 13 28.16 10.99 / H1 2.80
988 194 3.63 / L1 9.33 2.71
1034 46 21.10 10.38 / H1 2.99
BRA-1/id-265 C: Combination 41 NA 32.32 10.13 / H1 2.90
536 495 20.44 8.52 2.96
582 46 10.80 7.44 / L4 2.94
671 89 7.03 7.23 / L2 2.94
699 28 8.75 9.24 2.85
704 5 32.09 9.47 2.69
723 19 17.79 9.94 2.89
BRA-1/id-42 A: Drug X 176 NA 16.56 8.88 2.75
477 301 16.49 8.11 2.95
534 57 18.71 8.78 2.95
550 16 11.44 9.53 2.99
275 263 29.52 9.50 2.85
431 156 22.29 9.11 2.88
781 350 10.06 9.10 2.82
794 13 28.16 10.99 / H1 2.80
988 194 3.63 / L1 9.33 2.71
1034 46 21.10 10.38 / H1 2.99
BRA-1/id-265 C: Combination 41 NA 32.32 10.13 / H1 2.90
536 495 20.44 8.52 2.96
582 46 10.80 7.44 / L4 2.94
671 89 7.03 7.23 / L2 2.94
699 28 8.75 9.24 2.85
704 5 32.09 9.47 2.69
723 19 17.79 9.94 2.89
BRA-1/id-42 A: Drug X 176 NA 16.56 8.88 2.75
477 301 16.49 8.11 2.95
534 57 18.71 8.78 2.95
550 16 11.44 9.53 2.99
569 19 21.66 10.32 / H2 3.00 / H1
608 39 24.61 7.95 / L2 2.78
675 67 23.49 8.46 2.83
BRA-1/id-65 B: Placebo 218 NA 0.05 / L1 7.13 / L2 2.83
230 12 24.33 8.04 2.75
269 39 8.18 9.05 2.91
413 144 14.12 8.05 2.78
639 226 24.86 7.09 / L3 2.93
762 123 19.38 8.49 2.78
868 106 31.52 8.49 2.96
BRA-1/id-93 A: Drug X 19 NA 14.69 9.15 2.79
608 39 24.61 7.95 / L2 2.78
675 67 23.49 8.46 2.83
BRA-1/id-65 B: Placebo 218 NA 0.05 / L1 7.13 / L2 2.83
230 12 24.33 8.04 2.75
269 39 8.18 9.05 2.91
413 144 14.12 8.05 2.78
639 226 24.86 7.09 / L3 2.93
762 123 19.38 8.49 2.78
868 106 31.52 8.49 2.96
BRA-1/id-93 A: Drug X 19 NA 14.69 9.15 2.79
————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
NCI CTCAE grade is displayed as abnormal high (H) or low (L) followed by the grade.
Expand Down
Loading

0 comments on commit 00bbf7d

Please sign in to comment.